Pseudo-Progression and the Neutrophil-to-Lymphocyte Ratio in Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Case–Control Study

PURPOSE: Pseudo-progression (PsPD) is a rare phenomenon observed in <5% of cases of non-small cell lung cancer (NSCLC). This event is challenging for both clinicians and patients. Viable biomarkers to distinguish between PsPD and true progressive disease (TPD) are lacking. The aim of our study wa...

Full description

Saved in:
Bibliographic Details
Published in:Onco Targets Ther
Main Authors: Kiriu, Tatsunori, Yamamoto, Masatsugu, Nagano, Tatsuya, Hazama, Daisuke, Sekiya, Reina, Katsurada, Masahiro, Katsurada, Naoko, Tachihara, Motoko, Kobayashi, Kazuyuki, Nishimura, Yoshihiro
Format: Artigo
Language:Inglês
Published: Dove 2019
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6897378/
https://ncbi.nlm.nih.gov/pubmed/31819535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S228138
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items